Reduced Motivation in Perinatal Fluoxetine-Treated Mice: A Hypodopaminergic Phenotype
- 3 February 2021
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 41 (12), 2723-2732
- https://doi.org/10.1523/jneurosci.2608-20.2021
Abstract
Early life is a sensitive period, in which enhanced neural plasticity allows the developing brain to adapt to its environment. This plasticity can also be a risk factor in which maladaptive development can lead to long-lasting behavioral deficits. Here, we test how early-life exposure to the selective-serotonin-reuptake-inhibitor (SSRI), fluoxetine, affects motivation, and dopaminergic signaling in adulthood. We show for the first time that mice exposed to fluoxetine in the early postnatal period exhibit a reduction in effort-related motivation. These mice also show blunted responses to amphetamine and reduced dopaminergic activation in a sucrose reward task. Interestingly, we find that the reduction in motivation can be rescued in the adult by administering bupropion, a dopamine-norepinephrine reuptake inhibitor used as an antidepressant and a smoke cessation aid but not by fluoxetine. Taken together, our studies highlight the effects of early postnatal exposure of fluoxetine on motivation and demonstrate the involvement of the dopaminergic system in this process. SIGNIFICANCE STATEMENT The developmental period is characterized by enhanced plasticity. During this period, environmental factors have the potential to lead to enduring behavioral changes. Here, we show that exposure to the SSRI fluoxetine during a restricted period in early life leads to a reduction in adult motivation. We further show that this reduction is associated with decreased dopaminergic responsivity. Finally, we show that motivational deficits induced by early-life fluoxetine exposure can be rescued by adult administration of bupropion but not by fluoxetine.Funding Information
- HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD095966, HD094978)
This publication has 69 references indexed in Scilit:
- Dopaminergic Modulation of Effort-Related Choice Behavior as Assessed by a Progressive Ratio Chow Feeding Choice Task: Pharmacological Studies and the Role of Individual DifferencesPLOS ONE, 2012
- Deficits in Dopamine D2 Receptors and Presynaptic Dopamine in Heroin Dependence: Commonalities and Differences with Other Types of AddictionBiological Psychiatry, 2012
- The role of serotonin receptor subtypes in treating depression: a review of animal studiesPsychopharmacology, 2010
- Dissecting components of reward: ‘liking’, ‘wanting’, and learningCurrent Opinion in Pharmacology, 2009
- How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systemsNeuropharmacology, 2008
- PRECLINICAL STUDY: Teratogenic effects of maternal antidepressant exposure on neural substrates of drug‐seeking behavior in offspringAddiction Biology, 2007
- Increasing use of antidepressants in pregnancyAmerican Journal of Obstetrics and Gynecology, 2007
- Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during developmentDevelopmental Brain Research, 2004
- Transient postnatal elevation of serotonin levels in mouse neocortexDevelopmental Brain Research, 1988
- Ontogeny of monoamine neurons in the locus coeruleus, raphe nuclei and substantia nigra of the rat. I. Cell differentiationJournal of Comparative Neurology, 1974